🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07299227
Recruiting Observational

Impact of BPA in CTEPH on Cardiac and Pulmonary Physiology Assessed by CMR-derived 4D Flow Haemodynamics

NCT07299227 · tracked via the Priya Life Science Germany tracker
Sponsor
Kerckhoff Klinik
Phase
Observational
Started
2025-09-01
Last updated
2025-12-23

Condition(s) studied

CTEPH

Study summary

Patients with CTEPH referred for evaluation and conduction of BPA undergo standard of care diagnostic tests and treatment. This includes conventional echocardiographic, RHC and non-invasive (CT/CMR) or invasive (coronary angiography) coronary artery disease work-up. BPA will be conducted in generally 5 to 6 consecutive sessions. CMR will be performed prior to first and following the last intervention. Patient recruitment will be performed within 3 years, that is the last BPA session of the last patient in will have been performed at 3 years time.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * Patient referred to BPA * clinical indication for CMR * capability to give informed consent Exclusion Criteria: * general: non-compliance, \<18 years of age, pregnancy * contraindications for CMR (non-CMR compatible device, chronic kidney disease (eGFR \<30ml/min), allergies (medications)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kerckhoff-Klinik Bad Nauheim Hesse Recruiting

More Kerckhoff Klinik trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07299227 on ClinicalTrials.gov ↗ ← All trials in Germany